Amedica, a biomaterials company, has announced collaboration with Kyocera Industrial Ceramics, a ceramics producer, to manufacture medical devices from Amedica's silicon nitride biomaterial at Kyocera's Vancouver, Washington facility. ...
Tags: Health, Medicine, biomaterials
US-based Bruker has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its MALDI Biotyper CA system to identify Gram negative bacterial colonies cultured from human specimens. Bruker's MALDI Biotyper CA system ...
Novogen, a biotechnology company, has announced the filing of a family of provisional patents in the US covering anti-tropomyosin (ATM) drug technology. ATM drugs represent an entirely novel approach to anti-cancer therapy, blocking the ...
VBL Therapeutics has secured fast track status from the US Food and Drug Administration (FDA) for its lead oncology drug VB-111, for prolongation of survival in patients with Recurrent Glioblastoma Multiforme (rGBM). VB-111 was already ...
US-based BioMedical Enterprises (BME) has obtained the US Food and Drug Administration (FDA) clearance (K131640) for its upgraded HammerLock Nitinol intramedullary fixation system for hammertoe deformities. The patent-pending HammerLock ...
The US Food and Drug Administration (FDA) has approved Merck's Noxafil (posaconazole) 100 mg delayed-release tablets. The tablets are a new formulation with a loading dose of 300mg (three 100mg delayed-release tablets) twice daily on the ...
QRxPharma, an Australian-based commercial-stage specialty pharmaceutical company, has resubmitted its MOXDUO new drug application (NDA). At a meeting in early October 2013, the US Food and Drug Administration (FDA) provided QRxPharma with ...
Tags: QRxPharma, Drug Application
US-based Biozone Pharmaceuticals has announced that it has agreed to terms and signed a letter of intent (LOI) to merge with Cocrystal Discovery, a privately-held biotechnology company developing antiviral therapeutics for human diseases. ...
US-based research and development biotechnology firm Boston Strategics has entered into a new drug development partnership with Fujifilm Pharmaceuticals USA (FPHU), a global pharmaceutical development center of Japan's Fujifilm Corporation. ...
Tags: Oncology Drugs, Fujifilm Pharma
Canada-based ImStar Therapeutics has announced the selection of IMS-088 as its lead drug candidate for the treatment of amyotrophic lateral sclerosis. IMS-088 is a novel, small-molecule drug that stems from the discovery of a new target ...
US-based pharmaceutical firm Egalet has entered into a definitive collaboration and license agreement with Japan-based Shionogi for the development and commercialization of multiple oral abuse-deterrent hydrocodone opioid product candidates ...
Tags: Egalet, Product Candidates
A research paper published in the scientific journal Tobacco Control shows that graphic warning labels on cigarette packs led to a decrease in smoking rates in Canada of between 12% and 20% from 2000 to 2009. The authors estimate that if ...
The European Medicines Agency (EMA) has fully validated and granted accelerated assessment to Boehringer Ingelheim's application for European marketing authorization of faldaprevir, a potent second generation oral protease inhibitor. ...
Anti-malarial treatments that act on a new target have the potential to cure, prevent and block the transmission of the disease, U.S. researchers said. The as-yet undeveloped treatments would target an enzyme essential for the growth and ...
Tags: Anti-malarial, treatment, act, target, parasite
Dan Peters, owner of Lancaster Bicycle, passed away Nov. 22 after a long battle with cancer. He was 41. Before opening Lancaster Bicycle four years ago, Peters managed Bike Source in Columbus and at one time worked for Kenda as a sales ...
Tags: Ohio, retailer, industry, veteran, Dan Peters, pass away